COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 499: Articles 4981-4990  | Next

Determining latent features and forecasting of COVID-19 hospitalisations in Malaysia using a national patient assessment data platform: a study of machine learning modelling against expert system
Yee, H. J., Boo, I., Tan, I. K. T., Tan, J. S., Zakariah, H.
10.1101/2023.01.17.22281858 — Posted: 2023-01-18
Assessment of Willingness to Receive COVID-19 Vaccine and Associated Factors among Teachers in Dambi Dollo Town, Qellem Wallaga Zone, Oromia Regional State, Ethiopia: Institution based cross sectional study
Mengesha, d. S., Melaku, C., Ayana, L. A., Benti, T. K.
10.1101/2023.01.17.23284660 — Posted: 2023-01-18
Mixed Attention with Deep Supervision for Delineation of COVID Infection in Lung CT
Dutta, P., Mitra, S.
10.1101/2023.01.17.23284673 — Posted: 2023-01-18
Suicide deaths during the COVID-19 pandemic in the United States, by region, March 1, 2020-June 30, 2022
Faust, J. S., Renton, B., Du, C., Shah, S. B., Chen, A. J., Li, S.-X., Krumholz, H. M.
10.1101/2023.01.18.23284681 — Posted: 2023-01-18
Assessment of Retrospective Collection of EQ-5D-5L in US Patients with COVID-19
Sun, X., Di Fusco, M., Puzniak, L., Coetzer, H., Zamparo, J. M., Tabak, Y. P., Cappelleri, J. C.
10.1101/2023.01.18.23284602 — Posted: 2023-01-18
Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody Screening
O'Reilly, S. R., Kenny, G., Alrawahneh, T., Francois, N., Angeliadis, M., de Masson d'Autume, V., Garcia Leon, A., Feeney, E. R., Yousif, O., Cotter, A., de Barra, E., Horgan, M., Mallon, P. W., Gautier, V.
10.1101/2023.01.18.23284713 — Posted: 2023-01-18
A deep generative model of the SARS-CoV-2 spike protein predicts future variants
Dhodapkar, R. M.
10.1101/2023.01.17.524472 — Posted: 2023-01-18
Discovery of highly potent small molecule pan-coronavirus fusion inhibitors
Curreli, F., Chau, K., Tran, T.-T., Nicolau, I., Ahmed, S., Das, P., Hillyer, C. D., Premenko-Lanier, M., Debnath, A. K.
10.1101/2023.01.17.524492 — Posted: 2023-01-18
A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease
Geng, Z. Z., Atla, S., Shaabani, N., Vulupara, V. R., Yang, K. S., Alugubelli, Y. R., Khatua, K., Chen, P.-H. C., Xiao, J., Blankenship, L. R., Ma, X. R., Vatansever, E. C., Cho, C.-C., Ma, Y., Allen, R., Ji, H., Xu, S., Liu, W. R.
10.1101/2023.01.17.524469 — Posted: 2023-01-18
Cell division tracing combined with single-cell transcriptomics reveals new cell types and differentiation paths in the regenerating mouse lung
Martins, L. R., Sieverling, L., Michelhans, M., Schiller, C., Erkut, C., Triana, S., Froehling, S., Velten, L., Glimm, H., Scholl, C.
10.1101/2023.01.18.524384 — Posted: 2023-01-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).